Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse

被引:8
作者
Satoh, Masaaki [1 ]
Saito, Makoto [1 ]
Tanaka, Kohsuke [1 ]
Iwanaga, Sumako [2 ]
Ali, Salem Nagla Elwy Salem [1 ,4 ]
Seki, Takahiro [5 ]
Okada, Seiji [2 ]
Kohara, Michinori [3 ]
Harada, Shinji [4 ]
Kai, Chieko [5 ]
Tsukiyama-Kohara, Kyoko [1 ]
机构
[1] Kumamoto Univ, Fac Life Sci, Dept Expt Phylaxiol, Kumamoto, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Kumamoto 8608556, Japan
[3] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo, Japan
[4] Kumamoto Univ, Fac Life Sci, Dept Med Virol, Kumamoto, Kumamoto 8608556, Japan
[5] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1138654, Japan
关键词
MV; HCV; E1; E2; Human PBL; NOD/Scid/Jak3null mouse;
D O I
10.1016/j.cimid.2010.02.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, we infected NOD/Scid/Jak3null mice engrafted human peripheral blood leukocytes (hu-PBL-NOJ) with measles virus Edmonston B strain (MV-Edm) expressing hepatitis C virus (HCV) envelope proteins (rMV-E1E2) to evaluate the immunogenicity as a vaccine candidate. Although human leukocytes could be isolated from the spleen of mock-infected mice during the 2-weeks experiment, the proportion of engrafted human leukocytes in mice infected with MV (10(3)-10(5) pfu) or rMV-E1E2 (10(4) pfu) was decreased. Viral infection of the splenocytes was confirmed by the development of cytopathic effects (CPEs) in co-cultures of splenocytes and B95a cells and verified using RT-PCR. Finally, human antibodies againstMVwere more frequently observed than E2-specific antibodies in serum from mice infected with a low dose of virus (MV, 10(0)-10(1) pfu, and rMV-E1E2, 10(1)-10(2) pfu). These results showed the possibility of hu-PBL-NOJ mice for the evaluation of the immunogenicity of viral proteins. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:E81 / E88
页数:8
相关论文
共 41 条
[1]   Hepatitis C virus envelope glycoproteins and potential for vaccine development [J].
Beyene, A ;
Basu, A ;
Meyer, K ;
Ray, R .
VOX SANGUINIS, 2002, 83 :27-32
[2]   Mutational escape from CD8+ T cell immunity:: HCV evolution, from chimpanzees to man [J].
Bowen, DG ;
Walker, CM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (11) :1709-1714
[3]   Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus [J].
Brandler, Samantha ;
Lucas-Hourani, Marianne ;
Moris, Arnaud ;
Frenkiel, Marie-Pascale ;
Combredet, Chantal ;
Fevrier, Michele ;
Bedouelle, Hugues ;
Schwartz, Olivier ;
Despres, Philippe ;
Tangy, Frederic .
PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (03)
[4]   Recombinant vector derived from live attenuated measles virus: Potential for flavivirus vaccines [J].
Brandler, Samantha ;
Tangy, Frederic .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2008, 31 (2-3) :271-291
[5]   Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection -: a pilot study [J].
Bruchfeld, A ;
Ståhle, L ;
Andersson, J ;
Schvarcz, R .
JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) :287-292
[6]   Studies of hepatitis C virus in chimpanzees and their importance for vaccine development [J].
Bukh, J ;
Forns, X ;
Emerson, SU ;
Purcell, RH .
INTERVIROLOGY, 2001, 44 (2-3) :132-142
[7]   Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma [J].
Cantarella, Giuseppina ;
Liniger, Matthias ;
Zuniga, Armando ;
Schiller, John T. ;
Billeter, Martin ;
Naim, Hussein Y. ;
Glueck, Reinhard .
VACCINE, 2009, 27 (25-26) :3385-3390
[8]   A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in Macaques and transgenic mice [J].
Combredet, C ;
Labrousse, V ;
Mollet, L ;
Lorin, C ;
Delebecque, F ;
Hurtrel, B ;
McClure, H ;
Feinberg, MB ;
Brahic, M ;
Tangy, F .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11546-11554
[9]  
De Beeck AO, 2001, J GEN VIROL, V82, P2589, DOI 10.1099/0022-1317-82-11-2589
[10]   Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis [J].
Desprès, P ;
Combredet, C ;
Frenkiel, MP ;
Lorin, C ;
Brahic, M ;
Tangy, F .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) :207-214